Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$77.17
+0.4%
$71.39
$43.56
$79.20
$97.46B0.67.52 million shs4.61 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$27.34
-0.7%
$26.06
$23.15
$59.73
$10.76B2.0112.29 million shs6.06 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$26.27
-0.6%
$24.76
$20.92
$30.43
$150.27B0.5562.68 million shs47.61 million shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
+0.40%+2.47%+4.62%+15.78%+18.25%
Moderna, Inc. stock logo
MRNA
Moderna
-0.73%+5.85%+8.75%-16.62%-53.44%
Pfizer Inc. stock logo
PFE
Pfizer
-0.68%+3.18%+5.69%+2.78%-10.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$77.17
+0.4%
$71.39
$43.56
$79.20
$97.46B0.67.52 million shs4.61 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$27.34
-0.7%
$26.06
$23.15
$59.73
$10.76B2.0112.29 million shs6.06 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$26.27
-0.6%
$24.76
$20.92
$30.43
$150.27B0.5562.68 million shs47.61 million shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
+0.40%+2.47%+4.62%+15.78%+18.25%
Moderna, Inc. stock logo
MRNA
Moderna
-0.73%+5.85%+8.75%-16.62%-53.44%
Pfizer Inc. stock logo
PFE
Pfizer
-0.68%+3.18%+5.69%+2.78%-10.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CVS Health Corporation stock logo
CVS
CVS Health
2.92
Moderate Buy$79.202.63% Upside
Moderna, Inc. stock logo
MRNA
Moderna
2.00
Hold$41.8152.94% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.37
Hold$28.418.15% Upside

Current Analyst Ratings Breakdown

Latest CVS, MRNA, and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/7/2025
CVS Health Corporation stock logo
CVS
CVS Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$84.00 ➝ $103.00
10/3/2025
Pfizer Inc. stock logo
PFE
Pfizer
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$28.00 ➝ $30.00
10/1/2025
Pfizer Inc. stock logo
PFE
Pfizer
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$28.00
9/27/2025
CVS Health Corporation stock logo
CVS
CVS Health
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
9/27/2025
Moderna, Inc. stock logo
MRNA
Moderna
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/27/2025
Pfizer Inc. stock logo
PFE
Pfizer
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
9/22/2025
CVS Health Corporation stock logo
CVS
CVS Health
Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$80.00 ➝ $85.00
9/8/2025
CVS Health Corporation stock logo
CVS
CVS Health
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
9/5/2025
CVS Health Corporation stock logo
CVS
CVS Health
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetMarket Perform$72.00 ➝ $77.00
9/4/2025
CVS Health Corporation stock logo
CVS
CVS Health
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$80.00 ➝ $87.00
8/26/2025
CVS Health Corporation stock logo
CVS
CVS Health
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$78.00
(Data available from 10/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CVS Health Corporation stock logo
CVS
CVS Health
$372.81B0.26$9.12 per share8.46$60.18 per share1.28
Moderna, Inc. stock logo
MRNA
Moderna
$3.24B3.30N/AN/A$28.33 per share0.97
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.35$4.33 per share6.06$15.62 per share1.68
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CVS Health Corporation stock logo
CVS
CVS Health
$4.61B$3.5821.5611.400.851.17%10.51%3.15%10/29/2025 (Estimated)
Moderna, Inc. stock logo
MRNA
Moderna
-$3.56B-$7.53N/AN/AN/A-94.31%-25.96%-20.09%11/6/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.8813.978.670.8616.84%21.42%9.12%11/4/2025 (Estimated)

Latest CVS, MRNA, and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2025Q3 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.79N/AN/AN/A$16.94 billionN/A
10/29/2025Q3 2025
CVS Health Corporation stock logo
CVS
CVS Health
$1.36N/AN/AN/A$98.85 billionN/A
8/5/2025Q2 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.58$0.78+$0.20$0.51$13.43 billion$14.65 billion
8/1/2025Q2 2025
Moderna, Inc. stock logo
MRNA
Moderna
-$2.99-$2.13+$0.86-$2.13$116.26 million$142.00 million
7/31/2025Q2 2025
CVS Health Corporation stock logo
CVS
CVS Health
$1.46$1.81+$0.35$0.80$94.87 billion$98.92 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CVS Health Corporation stock logo
CVS
CVS Health
$2.663.45%N/A74.30%4 Years
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.55%N/A91.49%16 Years

Latest CVS, MRNA, and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/17/2025
CVS Health Corporation stock logo
CVS
CVS Health
quarterly$0.66503.59%10/23/202510/23/202511/3/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CVS Health Corporation stock logo
CVS
CVS Health
0.74
0.80
0.62
Moderna, Inc. stock logo
MRNA
Moderna
N/A
3.93
3.77
Pfizer Inc. stock logo
PFE
Pfizer
0.65
1.16
0.85

Institutional Ownership

CompanyInstitutional Ownership
CVS Health Corporation stock logo
CVS
CVS Health
80.66%
Moderna, Inc. stock logo
MRNA
Moderna
75.33%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
CVS Health Corporation stock logo
CVS
CVS Health
1.22%
Moderna, Inc. stock logo
MRNA
Moderna
11.00%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
CompanyEmployeesShares OutstandingFree FloatOptionable
CVS Health Corporation stock logo
CVS
CVS Health
300,0001.27 billion1.25 billionOptionable
Moderna, Inc. stock logo
MRNA
Moderna
5,800390.58 million346.28 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
81,0005.69 billion5.68 billionOptionable

Recent News About These Companies

Pfizer Inc. $PFE Shares Sold by NBT Bank N A NY
Brokerages Set Pfizer Inc. (NYSE:PFE) Target Price at $28.41
Life sciences sentiment rises as Pfizer deal eases tariff concerns
Down 50%, Should You Buy the Dip on Pfizer?
Down 50%, Should You Buy the Dip on Pfizer?
TrumpRx Brings Pfizer Into the Green-Is It a Buy?
Smartphone with Pfizer Logo against blue tablets and capsules Background — Stock Editorial Photography
TrumpRx Brings Pfizer Into the Green—Is It a Buy?
...

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
CVS Health stock logo

CVS Health NYSE:CVS

$77.17 +0.33 (+0.43%)
Closing price 10/7/2025 03:59 PM Eastern
Extended Trading
$77.36 +0.20 (+0.25%)
As of 09:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Moderna stock logo

Moderna NASDAQ:MRNA

$27.34 -0.20 (-0.73%)
Closing price 10/7/2025 04:00 PM Eastern
Extended Trading
$27.32 -0.02 (-0.07%)
As of 09:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Pfizer stock logo

Pfizer NYSE:PFE

$26.27 -0.16 (-0.61%)
Closing price 10/7/2025 03:59 PM Eastern
Extended Trading
$26.42 +0.15 (+0.56%)
As of 09:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.